Alzheimer’s Disease

1:39
Astrocytes and Alzheimer’s disease: neuroprotective or neurotoxic?
Beatriz Perez-Nievas
1:50
Neuropsychology education in society: building awareness
Shanti Shanker
2:18
The BRANES project: building resilience and awareness through neuropsychology education
Shanti Shanker
1:52
Lothian Birth Cohort 1936: a significant resource for studying lifetime cognition
Tara Spires-Jones
1:24
ApoE4 and clusterin: partners in crime in Alzheimer’s synaptic degeneration
Tara Spires-Jones
1:22
Alzheimer’s disease: from progress to progress
Tara Spires-Jones
1:09
Synapse loss and cognitive decline in ALS: a common feature with Alzheimer’s?
Tara Spires-Jones
2:04
Targeting proteostasis for the treatment of neurodegenerative diseases
John Skidmore
1:25
What’s in store for research into Alzheimer’s disease?
Delphine Boche
1:10
What are the next steps in dementia research?
Nigel Hooper
1:34
3D culture models for the study of dementia
Nigel Hooper
2:31
Tau fragments as novel disease biomarkers: a pilot study for a plasma protein signature for AD
Nigel Hooper
0:53
MODEM: modeling the number of dementia cases to improve future care
Martin Knapp
2:13
Policy: a vital component of improving dementia prevention and treatment
Martin Knapp
2:54
The link between the gut microbiome and the blood-brain barrier
Lesley Hoyles
1:42
Effects of gut-derived trimethylamines on the blood-brain barrier
Lesley Hoyles
The content of VJDementia is intended for healthcare professionals